Drug Recall of Rofecoxib

/in /by

As one of the most widely-used prescriptions withdrawn from the market, Rofecobix highlights issues facing public health leaders during a drug recall. With approval by the Food and Drug Administration in 1999, Merck marketed the drug for public use. In 2004, the drug was recalled for safety and cardiovascular problems developed in patients taking the medication (Topol, 2004). With nearly $2.5 billion dollars in sales and over 80 million people exposed to the drug, Merck’s recall turned into a public firestorm of litigation cases against the corporation. Use current events to consider facts of the case.

Provide a Case study analysis

  • In this paper include the following sections:
    • A summary of possible shortcomings of the skills and traits of the primary leaders in the case study
    • A summary of the facts associated with the case including the primary leaders
  • Please avoid redundancy, no paligarism, APA 6th eds, provide references and citations.